BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7125957)

  • 1. The thin-film adsorber hemoperfusion device: development and evaluation of clearance characteristics.
    Cooney DO; Kane RP
    Artif Organs; 1982 May; 6(2):151-62. PubMed ID: 7125957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The thin-film adsorber hemoperfusion device: detailed mass transfer and flow characteristics.
    Cooney DO; Kane RP
    Artif Organs; 1983 May; 7(2):197-207. PubMed ID: 6191743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies of hemoperfusion devices. I. In vitro clearance characteristics.
    Cooney DO; Infantolino W; Kane R
    Biomater Med Devices Artif Organs; 1978; 6(3):199-213. PubMed ID: 728514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The best coating material for hemoperfusion: comparation of cellulose nitrate with cellulose acetate and derivatives.
    Pişkin E; Cakmakli C; Ozdural AR
    Int J Artif Organs; 1981 Mar; 4(2):86-8. PubMed ID: 7275339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass transfer characteristics of hollow-fiber dialyzers and hemoperfusion devices.
    Cooney DO; Daly JS
    Artif Organs; 1979 Aug; 3(3):253-7. PubMed ID: 533416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hemoperfusion column based on activated carbon granules coated with an ultrathin membrane of cellulose acetate.
    Tijssen J; Bantjes A; van Doorn AW; Feijen J; van Dijk B; Vonk CR; Dijkhuis IC
    Artif Organs; 1979 Feb; 3(1):11-4. PubMed ID: 435118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coated carbon hemoperfusion provides limited clearance of protein-bound solutes.
    Dinh DC; Recht NS; Hostetter TH; Meyer TW
    Artif Organs; 2008 Sep; 32(9):717-24. PubMed ID: 18684207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adsorptive capacities of hemoperfusion devices in clinical use.
    Hampel G; Widdop B; Goulding R
    Artif Organs; 1978 Nov; 2(4):363-6. PubMed ID: 743006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of membrane thickness of collodion coated activated charcoal on adsorption of small and middle molecules.
    Morley D; Chang TM
    Biomater Artif Cells Artif Organs; 1987; 15(3):617-32. PubMed ID: 3440135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of activated charcoal hemoperfusion in removing lethal doses of barbiturates and salicylate from the blood of rats and dogs.
    Hill JB; Palaia FL; McAdams JL; Palmer PJ; Maret SM
    Clin Chem; 1976 Jun; 22(6):754-60. PubMed ID: 1277456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of uncoated activated carbon hemoperfusion in acute poisoning: in vitro studies.
    Tessore V; Luboz MP; Denti E
    Contrib Nephrol; 1982; 29():65-75. PubMed ID: 7075217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracorporeal treatment of salicylate or acetaminophen poisoning--is there a role?
    Winchester JF; Gelfand MC; Helliwell M; Vale JA; Goulding R; Schreiner GE
    Arch Intern Med; 1981 Feb; 141(3 Spec No):370-4. PubMed ID: 7008736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of polyetherurethane sheet embedded with powdered charcoal for use in hemoperfusion.
    Kawanishi H; Nishiki M; Sugiyama M; Cho T; Tsuchiya T; Ezaki H
    Artif Organs; 1984 May; 8(2):167-73. PubMed ID: 6732544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemoperfusion: state of the art and future requirements.
    Sideman S; Chang TM
    Artif Organs; 1980 Feb; 4(1):70-5. PubMed ID: 7369897
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical evaluation of the clearance profiles of a portable, compact, dialysate-free system incorporating microencapsulated charcoal hemoperfusion for blood purification with ultrafiltration for fluid removal.
    Chang TM; Chirito E; Barre P; Cole C; Lister C; Resurreccion E
    J Dial; 1977; 1(3):239-59. PubMed ID: 614387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with fixed-bred charcoal haemoperfusion in the treatment of severe drug intoxication.
    Hampel G; Crome P; Widdop B; Goulding R
    Arch Toxicol; 1980 Jul; 45(2):133-41. PubMed ID: 7469790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACAC (albumin-collodion coated activated charcoal) hemoperfusion: in-vitro removal and clearance of theophylline.
    Espinosa-Meléndez E; Chang TM
    J Dial; 1980; 4(1):21-9. PubMed ID: 7410675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vibrofluidized bed coating of hemoperfusion adsorbents.
    Morley DB
    ASAIO Trans; 1989; 35(2):139-43. PubMed ID: 2730812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coating membranes for a sorbent-based artificial liver: adsorption characteristics.
    de Koning HW; Chamuleau RA; Bantjes A
    Artif Organs; 1982 Aug; 6(3):280-7. PubMed ID: 7181728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present and future uses of hemoperfusion with sorbents.
    Winchester JF; Gelfand MC; Knepshield JH; Schreiner GE
    Artif Organs; 1978 Nov; 2(4):353-8. PubMed ID: 743004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.